Naturopathic practitioners' approach to caring for people with cardiovascular disease risk factors: A cross-cultural cross-sectional study reporting the providers perspective.

Cardiovascular disease Cardiovascular risk factors Naturopathic practitioners Naturopathy Patient care

Journal

Complementary therapies in clinical practice
ISSN: 1873-6947
Titre abrégé: Complement Ther Clin Pract
Pays: England
ID NLM: 101225531

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 17 02 2021
revised: 06 09 2021
accepted: 04 11 2021
pubmed: 13 11 2021
medline: 24 2 2022
entrez: 12 11 2021
Statut: ppublish

Résumé

and purpose: Naturopathic practitioners (NPs) in the United States (US) and Australia are consulted for the prevention and management of a range of health conditions, including cardiovascular disease (CVD). Despite this, little is known about how NPs approach the management of CVD risk factors. The aim of this study was to explore NPs approach to the care of people with CVD risk factors. In 2018, Australian and US NPs were recruited via professional representative organisations. A survey was developed containing four domains; naturopathic approaches to the clinical management of CVD risk factors, communication and sharing of information; professional-client relationship factors; and demographic information. The data analysis was conducted using the appropriate statistical tests. A total of 151 NPs completed the survey (Australia n = 75, US n = 76). NPs reported employing dietary, and multiple behavioural and natural product interventions to treat CVD risk factors. The most frequently recommended products by US and Australian NPs were fish oils (87%), magnesium (83%) and coenzyme Q10 (87%). Differences in what US and Australian NPs recommended were identified. NPs reported limited communication with medical doctors about their clients. NPs placed high importance on the relationship quality with their clients. US and Australian NPs represent an aspect of primary care and disease prevention that warrants further research that evaluates the potential risks and benefits of NP care, and challenges and opportunities associated with NPs integration into the healthcare systems, for populations with CVD risk factors.

Sections du résumé

BACKGROUND BACKGROUND
and purpose: Naturopathic practitioners (NPs) in the United States (US) and Australia are consulted for the prevention and management of a range of health conditions, including cardiovascular disease (CVD). Despite this, little is known about how NPs approach the management of CVD risk factors. The aim of this study was to explore NPs approach to the care of people with CVD risk factors.
MATERIALS AND METHODS METHODS
In 2018, Australian and US NPs were recruited via professional representative organisations. A survey was developed containing four domains; naturopathic approaches to the clinical management of CVD risk factors, communication and sharing of information; professional-client relationship factors; and demographic information. The data analysis was conducted using the appropriate statistical tests.
RESULTS RESULTS
A total of 151 NPs completed the survey (Australia n = 75, US n = 76). NPs reported employing dietary, and multiple behavioural and natural product interventions to treat CVD risk factors. The most frequently recommended products by US and Australian NPs were fish oils (87%), magnesium (83%) and coenzyme Q10 (87%). Differences in what US and Australian NPs recommended were identified. NPs reported limited communication with medical doctors about their clients. NPs placed high importance on the relationship quality with their clients.
CONCLUSION CONCLUSIONS
US and Australian NPs represent an aspect of primary care and disease prevention that warrants further research that evaluates the potential risks and benefits of NP care, and challenges and opportunities associated with NPs integration into the healthcare systems, for populations with CVD risk factors.

Identifiants

pubmed: 34768132
pii: S1744-3881(21)00210-3
doi: 10.1016/j.ctcp.2021.101511
pii:
doi:

Types de publication

Journal Article

Langues

eng

Pagination

101511

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Joanna E Harnett (JE)

The University of Sydney, Faculty of Medicine and Health, School of Pharmacy, Sydney, New South Wales, Australia; Australian Research Centre of Complementary and Integrative Medicine, Faculty of Health, University of Technology, Sydney, Australia. Electronic address: joanna.harnett@sydney.edu.au.

Catherine Rickwood (C)

Catherine Rickwood, Sydney, Australia. Electronic address: catherine@catherinerickwood.com.

Amie Steel (A)

Australian Research Centre of Complementary and Integrative Medicine, Faculty of Health, University of Technology, Sydney, Australia. Electronic address: amie.Steel@uts.edu.au.

Ryan Bradley (R)

Australian Research Centre of Complementary and Integrative Medicine, Faculty of Health, University of Technology, Sydney, Australia; National University of Natural Medicine, Portland, OR, USA; University of California, San Diego, La Jolla, CA, USA. Electronic address: rbradley@nunm.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH